3 news items
X4 Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates
XFOR
7 May 24
Long
X4 Pharmaceuticals Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Corporate Update
XFOR
21 Mar 24
of long
X4 Pharmaceuticals's Earnings Outlook
XFOR
20 Mar 24
10.12%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release
- Prev
- 1
- Next